CIBC Private Wealth Group
LAB icon

CIBC Private Wealth Group’s Standard BioTools LAB Stock Holding History

CIBC Private Wealth Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.79K Hold
1,400
– – ﹤0.01% 2817
2025
Q3 		$1.82K Hold
1,400
– – ﹤0.01% 2741
2025
Q2 		$1.68K Hold
1,400
– – ﹤0.01% 2680
2025
Q1 		$1.44K Buy
1,400
+500
+56% +$702 ﹤0.01% 2750
2024
Q4 		$1.57K Hold
900
– – ﹤0.01% 2734
2024
Q3 		$1.74K Hold
900
– – ﹤0.01% 2825
2024
Q2 		$1.67K Hold
900
– – ﹤0.01% 2796
2024
Q1 		$2.43K Buy
+900
New +$2.17K ﹤0.01% 2704

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

CIBC Private Wealth Group's LAB Position: Q4 2025 in Review

CIBC Private Wealth Group held its Standard BioTools (LAB) position steady in Q4 2025 at 1,400 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

CIBC Private Wealth Group first reported a position in LAB in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.43K in Q1 2024. 159 funds tracked by Wall St. Rank hold LAB as of Q4 2025.

  • CIBC Private Wealth Group held 1,400 shares of Standard BioTools worth $1.79K as of Q4 2025.
  • CIBC Private Wealth Group left its Standard BioTools share count unchanged in Q4 2025.
  • Standard BioTools made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2817 holding.
  • CIBC Private Wealth Group first reported a position in Standard BioTools in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Standard BioTools position peaked at $2.43K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.